Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs VanEck Junior Gold Miners (GDXJ) Price & Performance

ClearPoint Neuro IncTrade
VanEck Junior Gold MinersTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs VanEck Junior Gold Miners — how do they compare? ClearPoint Neuro Inc trades at $15.22 (market cap $454.21M), while VanEck Junior Gold Miners trades at $119.92. The key difference: VanEck Junior Gold Miners is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.

CLPTGDXJ
Market Cap
$454.21M
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$29.60$156.19
52-Week Low
$8.66$71.22
Enterprise Value
$488.79M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ClearPoint Neuro Inc

ClearPoint Neuro (CLPT) trades at $15.20, up 4.32% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue growth but missed earnings estimates, with a net income margin of -81.76%. Recent news highlights regulatory progress with partners and expansion into focused ultrasound technology.

The outlook remains speculative with high growth potential in neurotherapy markets, but significant execution and profitability risks persist. Analyst consensus is unanimously bullish, though sustained losses and cash burn require careful monitoring for long-term investors.

VanEck Junior Gold Miners

GDXJ, the VanEck Junior Gold Miners ETF, trades at $119.18, up 0.34% on the day, with a bullish technical signal driven by moving averages but tempered by overbought oscillators. Recent news highlights institutional selling and underperformance versus peers, while the ETF's composition shows less small-cap exposure than advertised. Key support lies at $118, with resistance at $120.

The outlook is mixed: bullish momentum persists near-term, but high RSI readings and negative sentiment from articles like Seeking Alpha (2026-06-24) suggest caution. Risks include gold price volatility and Federal Reserve policy shifts, while institutional activity, such as Amundi's 50.5% stake reduction (Defense World, 2026-08-06), indicates skepticism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About VanEck Junior Gold Miners

GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.

Read more on GDXJ